Tentang Webinar Ini

Abstract:

The COVID-19 patients were first detected in China, in December 2019, then the novel virus with associated pneumonia and other diseases spread quickly to worldwide becoming a serious public health. Among various treatment options, cells or stem cells-based cellular therapies are being investigated, because of their regeneration ability and multipotency along with other features like immunomodulation, ant fibrosis and anti-inflammatory effects (Duygu Koyuncu Irmak et al, 2020).

Topic 1:

SARS-COV-2 Cellular Innate - Adaptive Immunity Challenges And Therapy Solutions

Speaker: DR. Apt Reviany V.Nidom, M.Farm

Coronavirus disease 2019 (COVID-19) is a respiratory infectious disease caused by Severe Acute Respiratory Syndrome Corona Virus 2 (SARS-CoV-2). This disease has been declared a pandemic by the World Health Organization (WHO) and is having severe effects on both individual lives and economies around the world. Infection with SARS-CoV-2 is characterized by a broad spectrum of clinical syndromes, which range from asymptomatic disease or mild influenza-like symptoms to severe pneumonia and acute respiratory distress syndrome.

The severity of COVID-19 is mainly related to host factors, especially cellular immune responses in patients. Patients with mild COVID-19 and improved patients with severe COVID-19 exhibit a normal immune response to effectively eliminate the virus.

Due to the lack of specific antiviral drugs, the body’s immune response is a crucial factor affecting disease progression and prognosis. Therefore, a better understanding of the cellular immune response during the progression from mild disease to potentially fatal COVID-19 is crucial for developing diagnostic markers and strategies for the therapy of COVID-19.

Topic 2:

Covid19 Portofolio – Challenges and Solutions

Speaker: Dave Yong Yang Bin

Speaker